Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 6528-6535 |
| Seitenumfang | 8 |
| Fachzeitschrift | International Journal of Pharmacy and Technology |
| Jahrgang | 6 |
| Ausgabenummer | 2 |
| Publikationsstatus | Veröffentlicht - 1 Juli 2014 |
| Extern publiziert | Ja |
Abstract
In this study, we investigated the secondary metabolic profile of the fungus Fusarium sacchari chromatographically. Fusaric acid and its analogs, fusaric acid methyl ester and 9,10-dehydrofusaric acid were identified and characterised by spectroscopic methods and reported for the first time as secondary metabolites isolated from the fungal extract of F. sacchari. The structure of fusaric acid was fully characterised by x-ray crystallography. Antitumor activity of fusaric acid was tested against larynx cell cancer line (HEP-2), breast cancer cell line (MCF-7), lung cancer cell line (A-549) and colon cancer cell line (HCT-116) and compared with cisplatin as a reference drug. Fusaric acid showed a moderate antitumor activity with IC50 65.9 μM against the HEP-2 cell line.
ASJC Scopus Sachgebiete
- Ingenieurwesen (insg.)
- Biomedizintechnik
- Pharmakologie, Toxikologie und Pharmazie (insg.)
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: International Journal of Pharmacy and Technology, Jahrgang 6, Nr. 2, 01.07.2014, S. 6528-6535.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Identification, Crystal structure and antitumor activity of fusaric acid from the sugarcane fungal pathogen, Fusarium sacchari
AU - Ghannam, Iman A.Y.
AU - Roaiah, Hanaa F.
AU - Hanna, Mona M.
AU - El-Nakkady, Sally S.
AU - Cox, Russell J.
PY - 2014/7/1
Y1 - 2014/7/1
N2 - In this study, we investigated the secondary metabolic profile of the fungus Fusarium sacchari chromatographically. Fusaric acid and its analogs, fusaric acid methyl ester and 9,10-dehydrofusaric acid were identified and characterised by spectroscopic methods and reported for the first time as secondary metabolites isolated from the fungal extract of F. sacchari. The structure of fusaric acid was fully characterised by x-ray crystallography. Antitumor activity of fusaric acid was tested against larynx cell cancer line (HEP-2), breast cancer cell line (MCF-7), lung cancer cell line (A-549) and colon cancer cell line (HCT-116) and compared with cisplatin as a reference drug. Fusaric acid showed a moderate antitumor activity with IC50 65.9 μM against the HEP-2 cell line.
AB - In this study, we investigated the secondary metabolic profile of the fungus Fusarium sacchari chromatographically. Fusaric acid and its analogs, fusaric acid methyl ester and 9,10-dehydrofusaric acid were identified and characterised by spectroscopic methods and reported for the first time as secondary metabolites isolated from the fungal extract of F. sacchari. The structure of fusaric acid was fully characterised by x-ray crystallography. Antitumor activity of fusaric acid was tested against larynx cell cancer line (HEP-2), breast cancer cell line (MCF-7), lung cancer cell line (A-549) and colon cancer cell line (HCT-116) and compared with cisplatin as a reference drug. Fusaric acid showed a moderate antitumor activity with IC50 65.9 μM against the HEP-2 cell line.
KW - Antitumor activity
KW - Crystal structure
KW - Fusaric acid
KW - Fusarium sacchari
KW - HPLC
UR - http://www.scopus.com/inward/record.url?scp=84911384153&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84911384153
VL - 6
SP - 6528
EP - 6535
JO - International Journal of Pharmacy and Technology
JF - International Journal of Pharmacy and Technology
IS - 2
ER -